• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 ECHELON; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 ECHELON; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number UNK-NV-ECHELON
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Sepsis (2067)
Event Date 08/01/2015
Event Type  Death  
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The purpose of the article was to present a new and straightforward technique (exchange-free technique [eft]) to enhance apposition of the surpass flow diverter (sfd), the only over-the-wire flow diverter currently available.  twenty-eight patients (20 females, 8 males, average age49 years old) with 30 treated aneurysms were identified.The mean aneurysm diameter was 10.2 ± 6.6 mm.Technical success rate was 96.6% (29/30 aneurysms).There was no mortality or permanent morbidity related to the procedures.Except for the patient treated for an iatrogenic, surgery-related internal carotid artery pseudoaneurysm who died secondary to consequences of multiple surgeries, no cases of mortality or permanent morbidity were noted.Complete aneurysm occlusion rates were 78.2%, 82.1%, and 95.2% at 0¿3, 3¿6, and 9¿12 months, respectively.None of the patients were re-treated.None of the patients had clinically significant thromboembolic or hemorrhagic complications after discharge.The patient with iatrogenic pseudoaneurysm was brought directly to the angiography suite from the operating room where she was having a transsphenoidal surgery.The patient had a lacerated ica for which endovascular treatment was performed.After treatment and past the acute period, the patient underwent multiple transsphenoidal surgeries due to extensive involvement of the skull base with carcinoma.The patient died 53 days after the endovascular procedure secondary to postoperative sepsis.Otherwise, there were no permanent morbidity, mortality, or bleeding complications.  eft is a simple and fast technique which was not associated with adverse effects in our series.The higher aneurysm obliteration rate obtained with eft is probably the result of better wall apposition of the sfd.  there were no device issues reported relating to the use of the navien or echelon microcatheter.  adverse events included: 1.Sepsis 2.Death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ECHELON
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key16480917
MDR Text Key310642946
Report Number2029214-2023-00404
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeTU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-NV-ECHELON
Device Catalogue NumberUNK-NV-ECHELON
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received02/23/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death; Other;
Patient Age49 YR
Patient SexFemale
-
-